Azenta Life Sciences (NASDAQ: AZTA) has entered into a global partnership with China-based Vazyme Biotech Co., Ltd (SHA: 688105) to enhance their joint “one-stop” service process. This collaboration covers a wide range of fields, including high-throughput sequencing, automated database building, raw material supply, experimental consumables, and sample storage. Financial details of the partnership have not been disclosed.
Historical Collaboration and Future Directions
Vazyme initially partnered with GENEWIZ, the genomics service unit of Azenta (then known as Brooks Life Sciences), in 2016. Building on this foundation, the two companies will now collaborate on automated sample solutions, primer synthesis, molecular biology services, and GLP standard specification services on a global scale.
Focus on Research and Development
Vazyme Biotech is dedicated to the research and development of technology and products in the areas of enzymes, antigens, antibodies, and polymer organic materials. Azenta, on the other hand, is a leading global provider of life sciences solutions. This partnership combines Vazyme’s expertise in genomic research with Azenta’s broad range of life sciences services, positioning both companies to offer comprehensive solutions to clients worldwide.-Fineline Info & Tech
